Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays
about
Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissueAccurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samplesWhole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumoursA systems approach to clinical oncology: focus on breast cancer.Profiling alternatively spliced mRNA isoforms for prostate cancer classification.Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue.Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT).Biomarker discovery for colon cancer using a 761 gene RT-PCR assay.Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.Expression profiling with RNA from formalin-fixed, paraffin-embedded materialRNA expression analysis from formalin fixed paraffin embedded tissues.A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyIdentification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis.A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistanceGene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.Analyses and interpretation of whole-genome gene expression from formalin-fixed paraffin-embedded tissue: an illustration with breast cancer tissues.A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues.qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASLĀ® platform.Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimensA methodology for utilization of predictive genomic signatures in FFPE samples.Genome-wide expression assay comparison across frozen and fixed postmortem brain tissue samples.HER3 and downstream pathways are involved in colonization of brain metastases from breast cancerGene expression in fixed tissues and outcome in hepatocellular carcinoma.Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.Patterns of expression of DNA repair genes and relapse from melanoma.Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples.Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.Androgen modulation of coregulator expression in prostate cancer cells.mRNA expression signature of Gleason grade predicts lethal prostate cancerProtein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomyGene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation.Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgeryPredicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
P2860
Q28742831-BEC23E3F-A92A-4590-AD24-14B0277CD063Q30747169-AA6EC912-ED9C-4F4D-B75D-A1F0EC11F96AQ30974811-EB39FD51-0DD8-444C-8AB1-39F656035F7EQ31151258-33C6337E-C263-4FCE-87C9-69A32043A511Q33238889-F3322E36-1FB0-4FE7-AC3F-C1396A2A9F6DQ33239651-8F29D50E-746B-4DE8-AAEB-3A8D13F063B0Q33270254-A2A09F5F-8093-40AF-A7F9-604BCFD565F4Q33291060-122A17AC-AA48-4538-85AB-AE140A8D971EQ33294142-45D923F8-395B-48E5-82A8-D704825FB368Q33296583-26E1841F-E6E0-48F1-9E40-8E87C20837D5Q33329308-2AB94C03-52C4-46F4-A38A-412441A5AC9BQ33357619-9EF339AA-E661-4727-8AA8-BB3AA05FACC7Q33375063-F7178CE3-6F10-4EDB-9D83-7751FED69FA9Q33479558-938B98ED-F4DF-42F7-B6BF-EF0AB20913C4Q33516189-B6EE1666-7F13-488A-B79B-84015E719F6BQ33541296-8FAF7BBC-363B-4E2C-A863-5A0A0A181BF2Q33549674-32E07EE8-2253-496D-9E08-C56B5A7ECE48Q33622653-0CC9EEF2-9F26-4862-93D6-253FB2ED3625Q33741198-816A4A7C-8193-4A74-A4EC-478B77DF1D9DQ33772894-2530784B-9CF0-471F-B15F-8D902F366DB9Q33776119-CDBC8FE2-35EA-4984-B9B7-45DCD6F6C511Q33776184-282E27ED-CEAC-42E0-9E4F-52D2ACD4450DQ33896397-D656CA97-3420-4FD0-85CD-35BC78E9A62FQ33934517-9A677F81-932C-4A3A-9093-E2503420C981Q33957312-D0DDCD07-E6DD-468C-8EA1-719148A50599Q34015378-08B0320A-5021-4D5B-AD73-FE3504DE8B4FQ34173413-92771575-81E0-46DD-B644-A188CE777726Q34235518-4E5B7A4A-2740-4343-A171-E953F63F5AD5Q34243648-0B9F17E9-F16D-40BB-AAD2-2890400F6558Q34273603-5B6402E5-427D-439B-9E82-FAAF392CAA6AQ34391705-4B50125E-8314-4F68-BD80-FD6087545949Q34567052-B1E86204-1ADC-4AA5-A0B7-25EA62C7E94BQ34677558-DA147AE5-A5FC-4D38-A993-59B0E3BFC4B6Q34775924-5E83E787-2E77-49D5-9B6A-D71BBF9540CBQ34928162-A664C75A-8642-473A-8845-B48F15202C97Q35023464-AED51FBC-0926-4148-A169-B9F34A5005B3Q35070161-5482F8E2-B9A0-4773-8A22-84B755EFCFA7Q35071341-15F3777E-3B61-44AC-9149-6D92E3C77451Q35112054-EF69E58A-81AD-4E94-8F9A-AA21BC7B85E1Q35159916-DFB6CD78-3601-4A62-A308-F1EF4213F30E
P2860
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2004 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¶ÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
name
Quantitative gene expression p ...... es using universal bead arrays
@ast
Quantitative gene expression p ...... es using universal bead arrays
@en
type
label
Quantitative gene expression p ...... es using universal bead arrays
@ast
Quantitative gene expression p ...... es using universal bead arrays
@en
prefLabel
Quantitative gene expression p ...... es using universal bead arrays
@ast
Quantitative gene expression p ...... es using universal bead arrays
@en
P2093
P2860
P1476
Quantitative gene expression p ...... es using universal bead arrays
@en
P2093
David Atkins
David Barker
Dennis Doucet
Dimitri Talantov
Eliza Wickham
Eugene Chudin
Jian-Bing Fan
Joanne M Yeakley
P2860
P304
P356
10.1016/S0002-9440(10)63435-9
P407
P577
2004-11-01T00:00:00Z